Circulating liver function markers and the risk of COPD in the UK Biobank
Frontiers in Endocrinology · 2023
DOI: 10.3389/fendo.2023.1121900 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Endocrinology, 2023. Verfasst von Wencong Du und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Non-Communicable Chronic Disease Control, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Biological Specimen Banks, State Medicine. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: COPD
Abstract (Originalsprache)
Objective
To investigate the associations of circulating liver function marker levels with the risk of chronic obstructive pulmonary disease (COPD).
Methods
We leveraged the data of 372,056 participants from the UK Biobank between 2006 and 2010. The assessed circulating liver function markers included alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT), alkaline phosphatase (ALP), total bilirubin (TBIL), albumin (ALB), and total protein (TP). Incident COPD was identified through linkage to the National Health Service registries. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs).
Results
During a median follow-up period of 12.3 (interquartile range:11.4-13.2) years, we documented 10,001 newly diagnosed COPD cases. Lower levels of ALT, TBIL, ALB, and TP and higher levels of GGT and ALP were nonlinearly associated with elevated COPD risk. The HR (95% CI) for decile 10 vs. 1 was 0.92 (0.84-1.01) for ALT, 0.82 (0.75-0.89) for TBIL, 0.74 (0.67-0.81) for ALB, 0.96 (0.88-1.04) for TP, 1.45 (1.31-1.62) for GGT, and 1.31 (1.19-1.45) for ALP. Restricted cubic spline analyses suggested a U-shaped relationship between AST levels and COPD risk ( P for nonlinearity <0.05).
Conclusion
We observed that all seven circulating liver function markers were nonlinearly associated with the risk of COPD, indicating the importance of liver function in COPD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Non-Communicable Chronic Disease Control, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu, China.
- Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, China.
- Department of Chronic Disease Prevention and Control, Suzhou City Center for Disease Control and Prevention, Suzhou, China.
Zitieren
APA
Du, W., Guan, H., Wan, X., Zhu, Z., Yu, H., Luo, P., Chen, L., Su, J., Lu, Y., Hang, D., Tao, R., Wu, M., Zhou, J., & Fan, X. (2023). Circulating liver function markers and the risk of COPD in the UK Biobank. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2023.1121900
Vancouver
Du W, Guan H, Wan X, Zhu Z, Yu H, Luo P, et al. Circulating liver function markers and the risk of COPD in the UK Biobank. Frontiers in Endocrinology. 2023. doi:10.3389/fendo.2023.1121900
BibTeX
@article{Du2023,
author = {Du, Wencong and Guan, Haoyu and Wan, Xinglin and Zhu, Zheng and Yu, Hao and Luo, Pengfei and Chen, Lulu and Su, Jian and Lu, Yan and Hang, Dong and Tao, Ran and Wu, Ming and Zhou, Jinyi and Fan, Xikang},
title = {Circulating liver function markers and the risk of COPD in the UK Biobank},
journal = {Frontiers in Endocrinology},
year = {2023},
doi = {10.3389/fendo.2023.1121900}
}
EUVIMED